Clinical Trials in Chronic Lymphocytic Leukaemia (CLL)


Trial Title


Trial Description


More information (external website)




This trial is looking at how idelalisib works for people with chronic lymphocytic leukaemia (CLL). It is for people whose CLL came back or got worse whilst taking ibrutinib, or they are not able to have inbrutinib and they have been treated for their CLL before but it has come back or got worse.





This trial is comparing ibrutinib alongside rituximab with fludarabine, cyclophosphamide, rituximab and venetoclax for chronic lymphocytic leukaemia. This trial is for people who haven’t yet had treatment for their chronic lymphocytic leukaemia (CLL)




A trial for patients with previously untreated CLL, comparing BGB-3111 with Bendamustine plus Rituximab